Liver cancer is often hard to control with current treatments. To provide you with more options, your doctors may recommend that you consider taking part in a clinical study, also called a clinical trial. Fortunately, there are several clinical studies to treat liver cancer at Seattle Cancer Care Alliance (SCCA) and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine.
- See information about liver cancer clinical studies that are currently open and accepting SCCA patients.
- For general information about clinical studies, see the Patient Guide to Clinical Studies.
Clinical studies are carefully controlled research studies done with patients who volunteer. There are many requirements you must meet to be part of a study. If you qualify, it is up to you whether to take part.
Not all patients are cured with standard therapy, and some standard treatments may have side effects that patients and doctors would prefer to avoid, if possible. So patients may seek help through clinical studies. Patients who participate in studies have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease and potential new treatments.
Clinical Study Phases
Clinical studies come in four phases.
- In Phase I trials, researchers try to determine safe dose levels.
- In Phase II trials, which involve a larger group of patients, researchers hope to build on what they learned in the first phase by trying to establish whether cancers will respond to the safe dose levels and to determine what side effects will occur.
- In Phase III trials, researchers compare the experimental treatment with the standard treatment or a placebo to prove whether the new treatment is truly effective.
- In Phase IV trials, researchers monitor the effects of long-term usage.
Learn more about clinical studies.